GHP

MGI Tech Crowned in GHP's Biotechnology Awards 2024 as the Most Innovative Next-Gen Sequencing Company

Retrieved on: 
Wednesday, April 10, 2024
Genomics, GHP, Health, Research, NGS, Biotechnology, MGI, Fine chemical

SHENZHEN, China, April 10, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, proudly announces its recognition by Global Health & Pharma (GHP) Magazine's Biotechnology Awards 2024 as the Most Innovative Next-Gen Sequencing Company.

Key Points: 
  • SHENZHEN, China, April 10, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, proudly announces its recognition by Global Health & Pharma (GHP) Magazine's Biotechnology Awards 2024 as the Most Innovative Next-Gen Sequencing Company.
  • MGI remains committed to providing comprehensive, real-time solutions for diverse genetic sequencing needs."
  • Committed to advancing human health, MGI continuously pioneers cutting-edge sequencing technologies to support the healthcare sector in achieving its goals.
  • Congratulations to MGI Tech on its dedication to driving change, and we look forward to witnessing its continued success throughout 2024 and beyond."

Tivic Reports Fiscal Year 2023 Financial Results

Retrieved on: 
Monday, March 25, 2024
Biotechnology, Medical Devices, Biometrics, Health, Health Technology, Research, Congestion, VNS, GHP, Telephone, Vagus nerve stimulation, Medical device, Security (finance), Bank statement, System, Marketing, FDA, Advertising, Cryptocurrency

Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its financial results for the year ending December 31, 2023.

Key Points: 
  • Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its financial results for the year ending December 31, 2023.
  • “2023 was a year for both streamlining our commercial business and defining new opportunities for value creation,” stated Jennifer Ernst, CEO of Tivic.
  • Research and development expenses were approximately $1.7M for each of the years ended December 31, 2023 and December 31, 2022.
  • Management will host a webcast/conference call on Monday, March 25, 2024, at 1:30 PM PT / 4:30 PM ET to discuss the company’s year-end 2023 financial results and provide a business update, including comments on research directions undertaken in 2023.

Tomorrow Health and Geisinger Health Plan Release New Data Demonstrating Improved Home-Based Care Delivery

Retrieved on: 
Wednesday, November 1, 2023
Health, GHP, D.O, MBA, Geisinger Health System, ROI, Quality of life, Caregiver, Overalls, Patient, Nursing

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Tomorrow Health, the leading home-based healthcare platform, recently released new data with Geisinger Health Plan (GHP), illustrating how improving home-based care delivery can have measurable impacts on health plan costs, member satisfaction, and overall health outcomes for patients.

Key Points: 
  • Tomorrow Health technology platform drove 4x ROI, 95% member satisfaction
    NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Tomorrow Health , the leading home-based healthcare platform, recently released new data with Geisinger Health Plan (GHP), illustrating how improving home-based care delivery can have measurable impacts on health plan costs, member satisfaction, and overall health outcomes for patients.
  • "Tomorrow Health's transformative approach to home-based care has streamlined the entire process for our providers, suppliers, and patients," said Dr. John Bulger, D.O., MBA, chief medical officer at Geisinger Health Plan.
  • However, when Tomorrow Health began working with the health plan in 2021, Geisinger was having challenges delivering home-based care for its members, which resulted in costly operations and an unpredictable care experience for patients and their caregivers.
  • To learn more about Tomorrow Health and Geisinger Health Plan's work together, download a copy of "The Current State of Home-Based Care" here .

Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards

Retrieved on: 
Tuesday, October 24, 2023
WHO, Raman, Health care, GHP, Acquisition, Gene therapy, Patient, Bulletin of the World Health Organization, Global Health, Pharmaceutical industry, Oncology

SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.

Key Points: 
  • SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.
  • This recognition underscores Juniper Biologics' commitment to advancing healthcare by delivering groundbreaking therapies in the field of Oncology and oncology-supportive care.
  • The annual GHP Awards recognizes healthcare institutions, professionals, and trailblazers for their contributions to the remarkable progress in the healthcare and pharmaceutical fields.
  • Raman Singh, CEO of Juniper Biologics, expressed his appreciation for the company's recognition as the Most Innovative Oncology Pharmaceutical Company 2023 by GHP.

Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards

Retrieved on: 
Tuesday, October 24, 2023
WHO, Raman, Health care, GHP, Acquisition, Gene therapy, Patient, Bulletin of the World Health Organization, Global Health, Pharmaceutical industry, Oncology

SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.

Key Points: 
  • SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.
  • This recognition underscores Juniper Biologics' commitment to advancing healthcare by delivering groundbreaking therapies in the field of Oncology and oncology-supportive care.
  • The annual GHP Awards recognizes healthcare institutions, professionals, and trailblazers for their contributions to the remarkable progress in the healthcare and pharmaceutical fields.
  • Raman Singh, CEO of Juniper Biologics, expressed his appreciation for the company's recognition as the Most Innovative Oncology Pharmaceutical Company 2023 by GHP.

Enterprise Adoption of Geothermal Heat Pumps Will Create a US$18.5 Billion Market in 2030 as Sustainable Heating Takes Center Stage

Retrieved on: 
Thursday, October 12, 2023
Agriculture, Heat pump, Mitsubishi Group, Carrier, Indore, Heat, Research, Enterprise, City, GHP, Renewable energy, Heating, ventilation, and air conditioning, Roy Torbet

Finding suitable technology that can provide clean heating is now becoming a priority for many enterprises and industries.

Key Points: 
  • Finding suitable technology that can provide clean heating is now becoming a priority for many enterprises and industries.
  • Geothermal Heat Pumps (GHPs) offer solutions for cleaner heating, with options for cooling, which many industries are beginning to take advantage of.
  • "Where heat pumps cannot generate high temperatures past 150°C, they still find applications for using waste heat to repurpose it for general space/water heating or process heating that can operate at lower temperatures.
  • Approximately 415 thousand geothermal heat pump units were sold globally in 2022, ranging from small domestic use to large district heating projects.

Enterprise Adoption of Geothermal Heat Pumps Will Create a US$18.5 Billion Market in 2030 as Sustainable Heating Takes Center Stage

Retrieved on: 
Thursday, October 12, 2023
Agriculture, Heat pump, Mitsubishi Group, Carrier, Indore, Heat, Research, Enterprise, City, GHP, Renewable energy, Heating, ventilation, and air conditioning, Roy Torbet

Finding suitable technology that can provide clean heating is now becoming a priority for many enterprises and industries.

Key Points: 
  • Finding suitable technology that can provide clean heating is now becoming a priority for many enterprises and industries.
  • Geothermal Heat Pumps (GHPs) offer solutions for cleaner heating, with options for cooling, which many industries are beginning to take advantage of.
  • "Where heat pumps cannot generate high temperatures past 150°C, they still find applications for using waste heat to repurpose it for general space/water heating or process heating that can operate at lower temperatures.
  • Approximately 415 thousand geothermal heat pump units were sold globally in 2022, ranging from small domestic use to large district heating projects.

BioMech Health Wins Leading Specialists in Healthcare Real-Time Motion Analytics in the GHP Healthcare and Pharma Awards 2023

Retrieved on: 
Tuesday, September 26, 2023
Prevalence, Gait, GHP, Health care, Diabetic neuropathy, DSM-IV codes, Falls, Motion, Patient, Fracture, AI, Chronic pain, Medical device, Nursing

RICHMOND, Va., Sept. 26, 2023 (GLOBE NEWSWIRE) -- BioMech Health, LLC , a division of BioMech Holdings, LLC, today announced that it has been selected the winner of “Leading Specialists in Healthcare Real-time Motion Analytics” in the 2023 Global Health & Pharma Healthcare and Pharmaceutical Awards .

Key Points: 
  • RICHMOND, Va., Sept. 26, 2023 (GLOBE NEWSWIRE) -- BioMech Health, LLC , a division of BioMech Holdings, LLC, today announced that it has been selected the winner of “Leading Specialists in Healthcare Real-time Motion Analytics” in the 2023 Global Health & Pharma Healthcare and Pharmaceutical Awards .
  • BioMech Lab allows our patients to perform rehabilitative movements while AI/ML-enabled affixed motion sensors instantly and accurately “feed back” the movements using graphics and numerical display of information,” says Carter Brown, CEO of BioMech.
  • BioMech’s motion analytic solution, BioMech Lab, is driven by a proprietary AI engine that ingests motion data from their proprietary sensors to produce highly accurate, precise, and reproducible analyses.
  • Their AI engine, Coretex.AI rapidly trains, analyzes and tests models, teaching the machine to recognize/learn almost any pattern of motion and permitting the rapid deployment of new analytics.

The New York Geothermal Energy Organization (NY-GEO) - Commends New York State Governor Kathy Hochul for signing legislation that will Expand Opportunities for Geothermal Heating and Cooling for New York's Buildings

Retrieved on: 
Thursday, September 21, 2023
Dandelion Energy, Legislature, Consolidated Edison, Community, GHP, Environmental protection, Electricity, Sierra, Sierra Club, League of Conservation Voters, Temperature, Building, Climate Leadership and Community Protection Act, New Yorker, CLCPA, DEC, Natural gas, Climate, Climate Week NYC, Biophysical environment, Geothermal energy, Heat, Environment, New York State Department of Environmental Conservation, Legislation, Renewable energy

CAMBRIDGE, N.Y., Sept. 21, 2023 /PRNewswire/ -- New York Geothermal Energy Organization NY-GEO, a not-for-profit trade association, representing the geothermal heat pump (GHP) industry in New York State, celebrates the New York Governor for signing A6949/S6604 during Climate Week. 

Key Points: 
  • CAMBRIDGE, N.Y., Sept. 21, 2023 /PRNewswire/ -- New York Geothermal Energy Organization NY-GEO , a not-for-profit trade association, representing the geothermal heat pump (GHP) industry in New York State, celebrates the New York Governor for signing A6949/ S6604 during Climate Week.
  • The geothermal heat pump industry is installing hundreds of systems for New York building owners every year.
  • The new regulations created under this law will significantly increase access to geothermal across the state and help ensure New York meets its climate goals.
  • New York has not only become the State of Opportunity, but it has also become a leader in implementing renewable energy."

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

Retrieved on: 
Monday, September 11, 2023
HSCS, GHP, Intelligence, Global Health, Electrocardiography, Artificial intelligence, AI, Medical device

Southlake, TX, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has been named Electrocardiography Advancement Specialists of the Year 2023 – USA, in the Global Health & Pharma (GHP) Global Excellence Awards.

Key Points: 
  • Southlake, TX, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has been named Electrocardiography Advancement Specialists of the Year 2023 – USA, in the Global Health & Pharma (GHP) Global Excellence Awards.
  • "We are honored to receive this award and be recognized for advancing the field of electrocardiography using AI," said Andrew Simpson, CEO of HeartSciences.
  • HeartSciences was selected as a winner in recognition of its innovative work in AI-enabled electrocardiography advancement with its MyoVista® wavECG™ Technology.
  • The GHP Excellence Awards are presented annually to companies that have demonstrated excellence in their respective industries.